GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » File Forge Technology PLC (AQSE:FILE) » Definitions » Short-Term Debt

File Forge Technology (AQSE:FILE) Short-Term Debt : £0.00 Mil (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is File Forge Technology Short-Term Debt?

File Forge Technology's Short-Term Debt for the quarter that ended in . 20 was £0.00 Mil.


File Forge Technology Short-Term Debt Historical Data

The historical data trend for File Forge Technology's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

File Forge Technology Short-Term Debt Chart

File Forge Technology Annual Data
Trend
Short-Term Debt

File Forge Technology Semi-Annual Data
Short-Term Debt

File Forge Technology Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


File Forge Technology Short-Term Debt Related Terms

Thank you for viewing the detailed overview of File Forge Technology's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


File Forge Technology (AQSE:FILE) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
16 Great Queen Street, 9th Floor, London, GBR, WC2B 5DG
Clarify Pharma PLC is engaged in performing research or producing neuro-pharmaceutical drug development platforms that advance medicines through science and clinical trials. Its mission is to nurture the scientific advancement of mental, emotional, psychological, and physical health by investing in alternative therapies, modalities, and sciences.

File Forge Technology (AQSE:FILE) Headlines

No Headlines